LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 72.24 | 21.74 | 6045 | 6162 | 0.9810 | 0.9953 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 74.21 | 21.74 | 670 | 6235 | 0.1075 | 0.5218 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 74.21 | 21.74 | 5211 | 6235 | 0.8357 | 0.9565 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 74.21 | 21.74 | 14 | 6235 | 0.0022 | -0.0525 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 74.21 | 21.74 | 6346 | 6235 | 1.0177 | 1.0043 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 76.18 | 21.74 | 784 | 6114 | 0.1282 | 0.5538 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 76.18 | 21.74 | 5365 | 6114 | 0.8774 | 0.9681 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 76.18 | 21.74 | 15 | 6114 | 0.0025 | -0.0446 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 76.18 | 21.74 | 6668 | 6114 | 1.0905 | 1.0214 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 78.15 | 21.74 | 907 | 6167 | 0.1471 | 0.5807 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 78.15 | 21.74 | 5595 | 6167 | 0.9071 | 0.9762 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 78.15 | 21.74 | 16 | 6167 | 0.0026 | -0.0369 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 78.15 | 21.74 | 6896 | 6167 | 1.1181 | 1.0276 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 80.12 | 21.74 | 942 | 6211 | 0.1517 | 0.5872 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 80.12 | 21.74 | 5761 | 6211 | 0.9274 | 0.9816 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 80.12 | 21.74 | 18 | 6211 | 0.0029 | -0.0229 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 80.12 | 21.74 | 7163 | 6211 | 1.1531 | 1.0352 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 82.09 | 21.74 | 999 | 6201 | 0.1611 | 0.5989 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 82.09 | 21.74 | 5981 | 6201 | 0.9645 | 0.9912 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 82.09 | 21.74 | 28 | 6201 | 0.0045 | 0.0315 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 82.09 | 21.74 | 7455 | 6201 | 1.2022 | 1.0457 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 84.06 | 21.74 | 1090 | 6152 | 0.1772 | 0.6171 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 84.06 | 21.74 | 6193 | 6152 | 1.0066 | 1.0016 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 84.06 | 21.74 | 18 | 6152 | 0.0029 | -0.0229 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 84.06 | 21.74 | 7636 | 6152 | 1.2412 | 1.0538 | MN20160310_N01 | G15 |